Short answer
SBC Medical Group Holdings Inc (SBC) filed its Q1 2026 10-Q quarterly report on May 14, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $43M (down 9.0% year over year) with net income of $11M.
Q1 2026 key financials · XBRL
- Revenue
- $43M
- −9.0% YoY
- Net income
- $11M
- −47.4% YoY
- Operating margin
- 41.2%
- Gross margin
- 70.5%
- EPS (diluted)
- $0.11
- −47.6% YoY
Source: XBRL data from the SBC Medical Group Holdings Inc (SBC) Q1 2026 10-Q on SEC EDGAR. USD.
SBC Medical Group Holdings Inc Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $43.1M, down $4.3M YoY from $47.3M
- Net income $11.3M, down from $21.5M YoY
- Operating cash flow $9.2M, up from $1.9M YoY
- Retained earnings $251.8M as of March 31, 2026
- Strategy: expand Shonan Beauty Clinic brand across Japan, Vietnam, Singapore, and globally
Risk Factors
- No new or changed risk factors identified in the provided text
- Broad residual risk: unknown or currently immaterial risks could materially impair operations and depress securities trading price
- Regulatory compliance risk: future SEC filings may disclose additional or revised risk factors
- Insider-trading compliance risk: no directors or officers adopted, modified, or terminated Rule 10b5-1 arrangements during the three months ended March 31, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SBC Medical Group Holdings Inc quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.